These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 26938573)

  • 1. Practice Bulletin No. 162: Prenatal Diagnostic Testing for Genetic Disorders.
    Obstet Gynecol; 2016 May; 127(5):e108-e122. PubMed ID: 26938573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practice Bulletin No. 162 Summary: Prenatal Diagnostic Testing for Genetic Disorders.
    Obstet Gynecol; 2016 May; 127(5):976-978. PubMed ID: 27101119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practice Bulletin No. 163 Summary: Screening for Fetal Aneuploidy.
    Obstet Gynecol; 2016 May; 127(5):979-981. PubMed ID: 27101120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practice Bulletin No. 163: Screening for Fetal Aneuploidy.
    Obstet Gynecol; 2016 May; 127(5):e123-e137. PubMed ID: 26938574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin Summary, Number 226.
    Obstet Gynecol; 2020 Oct; 136(4):859-867. PubMed ID: 32976375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin, Number 226.
    ; ;
    Obstet Gynecol; 2020 Oct; 136(4):e48-e69. PubMed ID: 32804883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal Diagnosis Procedures and Techniques to Obtain a Diagnostic Fetal Specimen or Tissue: Maternal and Fetal Risks and Benefits.
    Wilson RD; Gagnon A; Audibert F; Campagnolo C; Carroll J;
    J Obstet Gynaecol Can; 2015 Jul; 37(7):656-668. PubMed ID: 26366824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of a DNA method, QF-PCR, in the prenatal diagnosis of fetal aneuploidies.
    Langlois S; Duncan A; ;
    J Obstet Gynaecol Can; 2011 Sep; 33(9):955-960. PubMed ID: 21923994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory.
    Petersen AK; Cheung SW; Smith JL; Bi W; Ward PA; Peacock S; Braxton A; Van Den Veyver IB; Breman AM
    Am J Obstet Gynecol; 2017 Dec; 217(6):691.e1-691.e6. PubMed ID: 29032050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal screening for and diagnosis of aneuploidy in twin pregnancies.
    Audibert F; Gagnon A; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):754-67. PubMed ID: 21749753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of prenatally diagnosed structural congenital anomalies.
    Gagnon A;
    J Obstet Gynaecol Can; 2009 Sep; 31(9):875-881. PubMed ID: 19941713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-invasive prenatal testing for aneuploidy: current status and future prospects.
    Benn P; Cuckle H; Pergament E
    Ultrasound Obstet Gynecol; 2013 Jul; 42(1):15-33. PubMed ID: 23765643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination.
    Dick PT
    CMAJ; 1996 Feb; 154(4):465-79. PubMed ID: 8630836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population-based trends in invasive prenatal diagnosis for ultrasound-based indications: two decades of change from 1994 to 2016.
    Lostchuck E; Poulton A; Halliday J; Hui L
    Ultrasound Obstet Gynecol; 2019 Apr; 53(4):503-511. PubMed ID: 29877030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carrier screening for thalassemia and hemoglobinopathies in Canada.
    Langlois S; Ford JC; Chitayat D; ;
    J Obstet Gynaecol Can; 2008 Oct; 30(10):950-959. PubMed ID: 19038079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Committee Opinion No. 640: Cell-Free DNA Screening For Fetal Aneuploidy.
    Obstet Gynecol; 2015 Sep; 126(3):e31-e37. PubMed ID: 26287791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening of fetal chromosomal aneuploidy diseases using noninvasive prenatal testing in twin pregnancies.
    Yu W; Lv Y; Yin S; Liu H; Li X; Liang B; Kong L; Liu C
    Expert Rev Mol Diagn; 2019 Feb; 19(2):189-196. PubMed ID: 30582381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Committee Opinion Summary No. 640: Cell-Free DNA Screening For Fetal Aneuploidy.
    Obstet Gynecol; 2015 Sep; 126(3):691-692. PubMed ID: 26287784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obstetrical complications associated with abnormal maternal serum markers analytes.
    Gagnon A; Wilson RD;
    J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.